💰The Funding Letter #1361: February 27

Alamar Biosciences, RobCo, Inkitt, and more...

February 27, 2024


Good Morning! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. 🔥New Sales Gigs from Qloo below!

Hit the Gong 🎉

Source: @sales_bant_er

Daily Deals 💸

🌎 Americas

Alamar Biosciences has developed a medical platform that brings ultra-high sensitivity and massively parallel scale to proteomic analysis, enabling healthcare providers to detect and possibly cure patients early. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $100M, Series C

Round Investors: Sands Capital Ventures (lead)

🚀Growth Focus: Grow the commercial and customer support teams, drive market adoption, and expand its product line.

HQ: Fremont, CA

Industry: Biotechnology Research

Employee Count: 90

b.well Connected Health provides a digital health engagement platform that simplifies communication and data management for hospitals, allowing the healthcare industry to improve reimbursement models as per compliance with information-blocking penalties in place. View on: LinkedIn.com | Sales Navigator.

New Funding Raised: $40M, Series C

Round Investors: Leavitt Equity Partners (lead)

🚀Growth Focus: Expand operations and its development effort.

HQ: Baltimore, MD

Industry: Hospitals and Health Care

Employee Count: 128

Subscribe to TFL All-Access Tier to read the rest.

Become a paying subscriber of TFL All-Access Tier to get access to this post and other subscriber-only content.

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Exclusive Access to The Funding Letter, delivering hundreds of leads to your inbox each month
  • • Searchable weekly, monthly, and annual datasets of funding announcement leads, so you can quickly find the most relevant data
  • • The hottest Sales Gigs in the industry, sourced from the fastest growing startups
  • • ..and much more to come!